300 related articles for article (PubMed ID: 22907485)
1. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
[TBL] [Abstract][Full Text] [Related]
2. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
[TBL] [Abstract][Full Text] [Related]
3. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.
Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H
J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714
[TBL] [Abstract][Full Text] [Related]
4. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.
Kuo HY; Chang WL; Yeh YC; Tsai YC; Wu CT; Cheng HC; Yang HB; Lu CC; Sheu BS
Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27220894
[TBL] [Abstract][Full Text] [Related]
5. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.
Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H
BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Park SM; Park J; Chang SK; Yoo BC; Kim HJ
Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
[TBL] [Abstract][Full Text] [Related]
7. Metaplasia of the duodenum shows a Helicobacter pylori-correlated differentiation into gastric-type protein expression.
Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Dekker J
Hum Pathol; 2003 Feb; 34(2):156-65. PubMed ID: 12612884
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
[TBL] [Abstract][Full Text] [Related]
9. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
Ohkusa T; Takashimizu I; Fujiki K; Araki A; Honda K; Shimoi K; Sakurazawa T; Horiuchi T; Suzuki S; Ariake K; Ishii K
J Clin Gastroenterol; 1997 Jul; 25(1):317-22. PubMed ID: 9412911
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner.
Reeves EP; Ali T; Leonard P; Hearty S; O'Kennedy R; May FE; Westley BR; Josenhans C; Rust M; Suerbaum S; Smith A; Drumm B; Clyne M
Gastroenterology; 2008 Dec; 135(6):2043-54, 2054.e1-2. PubMed ID: 18848942
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
15. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological investigation of the gastric surface mucous gel layer of patients with Helicobacter pylori infection by using immunoassays for trefoil factor family 2 and gastric gland mucous cell-type mucin in gastric juice.
Kubota S; Yamauchi K; Sugano M; Kawasaki K; Sugiyama A; Matsuzawa K; Akamatsu T; Ohmoto Y; Ota H
Dig Dis Sci; 2011 Dec; 56(12):3498-506. PubMed ID: 21559742
[TBL] [Abstract][Full Text] [Related]
17. [Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?].
Gisbert JP; Boixeda D; Vila T; de Rafael L; Alvarez Baleriola I; Martín de Argila C
Med Clin (Barc); 1995 Nov; 105(15):561-5. PubMed ID: 7500674
[TBL] [Abstract][Full Text] [Related]
18. Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.
Hoffmann W
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630599
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
Warson C; Van De Bovenkamp JH; Korteland-Van Male AM; Büller HA; Einerhand AW; Ectors NL; Dekker J
Hum Pathol; 2002 Jun; 33(6):660-8. PubMed ID: 12152167
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication.
Noh G; Kim N; Choi Y; Lee HS; Hwang YJ; Kim HJ; Yoon H; Shin CM; Park YS; Lee DH
J Gastroenterol Hepatol; 2020 Sep; 35(9):1540-1548. PubMed ID: 32090375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
